You are browsing content specific to your location, some treatments may not be available:

Endometrial Receptivity Analysis (ERA)

Endometrial Receptivity Analysis (ERA)

Endometrial Receptivity Analysis (ERA) is a test to assess the endometrial status and determine the presence of a receptive gene profile in the patient’s endometrium during the biopsy.

The human endometrium is a highly dynamic tissue that is capable of undergoing physiological changes in response to steroid hormones. Thus, it creates a receptive status that is synchronized with the arrival of an implanting blastocyst (refers to an embryo that is 5 days old after successful fertilization).

Who should consider ERA?

The ERA is considered in women who:

  • Experienced multiple implantation failures with embryo transfers despite good quality of the embryos
  • No previous pregnancies

What is Endometrial Receptivity Genome Analysis?

Endometrial Receptivity Genome Analysis is a state-of-the-art diagnostic method. This test evaluates the endometrial receptivity status from a molecular point of view. It helps to assess the receptivity for endometrium for implantation by analyzing the expression of a group of genes related to endometrial receptivity.

Types of treatment related to this article

IVF means in vitro fertilization. In vitro means in the laboratory ( outside the body) and fertiliza…
Intracytoplasmic sperm injection (ICSI) is a technique developed to overcome male infertility attrib…
Preimplantation genetic testing for aneuploidies (PGT‐A), formerly known as preimplantation geneti…